JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES) ›› 2015, Vol. 53 ›› Issue (3): 56-61.doi: 10.6040/j.issn.1671-7554.0.2014.744

Previous Articles     Next Articles

Changes of Runx2 and Osterix expression in type 1 diabetic rats and the intervention effect of zoledronic acid

ZHAO Xu, CUI Min, YU Lingzhi, ZHANG Na, CAO Luning   

  1. Department of Pain Management, Jinan Central Hospital Affiliated to Shandong University, Jinan 250013, Shandong, China
  • Received:2014-10-27 Revised:2015-02-28 Online:2015-03-10 Published:2015-03-10

Abstract: Objective To observe the levels of serum insulin and osteocalcin, osteoblast specific transcription factor Runx2 and Osterix (OSX) gene in type 1 diabetic rats, and the intervention effect of zoledronic acid. Methods A total of 170 Wistar rats were randomly divided into two groups:40 rats were enrolled into the control group the other animals were injected with streptozotocin (60 mg/kg) to establish type 1 diabetic models. After that, 120 rats in this group were randomly divided into the model group (n=40), prevention group (n=40) and treatment group (n=40). Rats in the prevention group and treatment group received a bolus injection of zoledronic acid (0.1 mg/kg) at the onset of diabetes and 2 weeks later, respectively. The serum INS and OC were detected with ELISA. Expressions of Runx2 and OSX mRNA in the right femur were detected with RT-PCR. Results ELISA results showed that the serum INS in the model group, prevention group and treatment group was significantly reduced compared with that in the control group (P<0.05). The serum OC was lower in the model group that in the control group (P<0.05), while higher in the prevention group than in the control group and model group (P<0.05). At week 12, serum OC was higher in the treatment group than in the prevention group (P<0.05). RT-PCR tests showed that the expressions of Runx2 andOSX mRNA were significantly lower in the model group than in the control group (P<0.05), while remarkably higher in the prevention group and treatment group than in the control group and model group (P<0.05). The upregulation was higher in the prevention group than in the model group. Conclusion Expressions of Runx2 and OSX mRNA were significantly decreased in the bone of type 1 diabetic rat models. Prophylactic use of zoledronic acid can improve the levels of serum OC, and reverse the decreasing expression of Runx2 and OSX mRNA, thus promoting bone formation.

Key words: Insulin, Osteocalcin, Runx2, Type 1 diabetes, Osterix, Zoledronic acid

CLC Number: 

  • R589
[1] Okazaki K, Sandell LJ. Extracellular matrix gene regulation[J]. Clin Orthop Relat Res, 2004, 427(Supp1):123-128.
[2] Nakashima K, Zhou X, Kunkel G, et al. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation[J]. Cell, 2002, 108(1):17-29.
[3] Choi C, Lee H, Lim H, et al. Effect of rubus coreanus extracts on diabetic osteoporosis by simultaneous regulation of osteoblasts and osteoblasts[J]. Menopause, 2012, 19(9):1043-1051.
[4] Mccabe LR. Understanding the pathology and mechanisms of type I diabetic bone loss[J]. J Cell Biochem, 2007, 102(6):1343-1357.
[5] 吴璇, 刘洪臣, 鄂玲玲, 等. 胰岛素对糖尿病大鼠下颌骨成骨细胞分化的影响[J]. 口腔医学研究, 2014, 30(5):407-410. WU Xuan, LIU Hongchen, E Lingling, et al. Effect of Insulin on differentiation of osteoblasts obtained from diabetic rats' mandible[J]. Journal of Oral Science Research, 2014, 30(5):407-410.
[6] Hou JM, Wu M, Lin QM, et al. Lactoferrin promote primary rat osteoblast proliferation and differentiation via up-regulation of insulin-like growth factor-1 expression[J]. Mol Biol Rep, 2014, 41(8):5019-5030.
[7] Enomoto H, Enomoto-Iwamoto M, Iwamoto M, et al. Cbfa1 is a positive regulatory factor in chondrocyte maturation[J]. J Biol Chem, 2000, 275(12):8695-8702.
[8] Wang WJ, Sun C, Liu Z, et al. Transcription factor Runx2 in the low bone mineral density of girls with adolescent idiopathic scoliosis[J]. Orthop Surg, 2014, 6(1):8-14.
[9] Ducy P, Starbuck M, Priemel M, et al. A Cbfa1-dependent genetic pathway controls bone formation beyond embryonic development[J]. Genes Dev, 1999, 13(8):1025-1036.
[10] Lu H, Kraut D, Gerstenfeld LC, et al. Diabetes interferes with the bone formation by affecting the expression of transcription factors that regulate osteoblast differentiation[J]. Endoc rinology, 2003, 144(1):346-352.
[11] 于灵芝, 张娜, 崔敏, 等. 脉冲电磁场对大鼠成骨细胞增殖、分化及osterix基因表达的影响[J]. 中华物理医学与康复杂志, 2012, 34(7):485-487. YU Lingzhi, ZHANG Na , CUI Min, et al. Effects of a pulsed electromagnetic field on cell proliferation, differentiation and osterix mRNA expression in rat osteoblasts[J]. Chinese Journal of Physical Medicine and Rehabilitation, 2012, 34(7):485-487.
[12] Matsubara T, Kida K, Yamaguchi A, et al. BMP2 regulates Osterix through Msx2 and Runx2 during osteoblast differentiation[J]. J Biol Chem, 2008, 283(43):29119-29125.
[13] Huang S, Lin H, Zhu X, et al. Zoledronic acid increases bone mineral density and improves health-related quality of life over two years of treatment in Chinese women with postmenopausal osteoporosis[J]. Endokrynol Pol, 2014, 65(2):96-104.
[14] 彭晨, 王志强, 李琪佳, 等. 唑来膦酸对大鼠成骨细胞增殖、分化和护骨素/核因子κB受体激动剂配体mRNA表达的影响[J]. 中国组织工程研究与临床康复, 2009, 13(22):4241-4244. PENG Chen, WANG Zhiqiang, LI Qijia, et al. Effect of zoledronic acid on proliferation and differentiation of osteoblasts as well as osteoprotegerin/nuclear factor-kappa B receptor agonist ligand mRNA expression[J]. Journal of Clinical Rehabilitative Tissue Engineering Research, 2009, 13(22):4241-4244.
[15] Farshdousti HM, Noruzinia M, Mortazavi Y, et al. Zoledrinic acid induces steoblastic differentiation of mesenchymal stem cells without change in hypomethylation status of OSTERIX promoter[J]. Cell J, 2012, 14(2):90-97.
[16] Fowlkes JL, Bunn RC, Liu L, et al. Runt-related transcription factor 2 (RUNX2) and RUNX2-related osteogenic genes are down-regulated throughout osteogenesis in type 1 diabetes mellitus[J]. Endocrinology, 2008, 149(4):1697-1704.
[17] Lee JH, Kim BG, Ahn JM, et al. Role of PI3K on the regulation of BMP2-induced beta-Catenin activation in human bone marrow stem cells[J]. Bone, 2010, 46(6):1522-1532.
[1] ZHANG Yuan, LI Yang-Min, FENG Rue-Qiu, CHANG Cai-Yun, PAN Hua-Wei, WANG Shu-Mei. Relationship among serum adiponectin level, obesity and insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2209, 47(6): 124-.
[2] DING Xiangyun, YU Qingmei, ZHANG Wenfang, ZHUANG Yuan, HAO Jing. Correlation of the expression of insulin-like growth factor II in granulosa cells and ovulation induction outcomes of 84 patients with polycystic ovary syndrome [J]. Journal of Shandong University (Health Sciences), 2020, 1(7): 60-66.
[3] JI Yuanyuan, BAO Jingbo, ZHAO Xu, CAO Luning, CUI Min, ZHANG Na, YU Lingzhi. IL-17F promotes the proliferation, mineralization and expressions of Runx2 and Osterix in rat osteoblasts [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(8): 24-29.
[4] LI Jian, XU Bing, YAN Xinfeng, XU Wanju, CHANG Xiaotian. Screening key genes for TXNDC5 and insulin signaling pathway [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(3): 88-93.
[5] LI Hongzhi, SHEN Yongchao, LIU Jieting, ZHAO Xiaojin, CHU Yanhui, YUAN Xiaohuan. An 11β-HSD1 inhibitor improves insulin sensitivity in db/db mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(10): 59-64.
[6] JIA Yueyue, LIU Hongbin, LI Jingbo, LI Jing, ZHANG Jiangtao, SUN Mei, SHI Yuhua. Expression of microRNA-200b in granulosa cells of PCOS patients and its significance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 63-68.
[7] LI Jingbo, LIU Hongbin, JIA Yueyue, WANG Ze, SUN Mei, SHI Yuhua. Expression and clinical significance of microRNA-183 in polycystic ovary syndrome with insulin resistance [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(1): 69-74.
[8] LIN Dong, GUAN Qingbo. Association of serum testosterone level and non-alcoholic fatty liver disease in male patients with T2DM [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(7): 33-37.
[9] XU Yibo, JI Xiaokang, LI Xiangyi, SHEN Zhenwei, XUE Fuzhong. Analysis on the relationship between urine pH and metabolic syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(12): 82-85.
[10] LI Dumin, WANG Qian, LI Chuanfu, WANG Qing. Two cases of multpile endoncrine neoplasia type 1 with Whipple syndrome [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(1): 62-66.
[11] YOU Jiebing, SUN Zhongwen, DU Juan, XU Wenjuan, WANG Yalin, LI Shuai, ZHU Meijia. Effects of rosiglitazone and insulin on the expression of TIPE2 and cell apoptosis in the brain of type 2 diabetic GK rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(4): 43-48.
[12] PEI Leilei, SUN Zhonghua, LI Zhe, ZHAO Wenping. Effects of sitagliptin combined with high-dose insulin on type 2 diabetes mellitus [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(2): 39-42.
[13] JIANG Fangjie, SHAO Shanshan, JING Fei, YU Chunxiao, ZHAO Jiajun. Fat-derived adipokine disorder in high cholesterol diet rats [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2015, 53(11): 1-5.
[14] LIU Chuan, HU Sanyuan, LIU Shaozhuang, ZHANG Guangyong, WANG Kexin, YU Wenbin. Clinical analysis of insulinoma resection:laparoscopy versus laparotomy [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(9): 67-71.
[15] ZHANG Yingzhe, WU Dongjin, PENG Changliang, LI Bohan, SONG Yang, ZHANG Cheng, ZHAO Jie, LI Dequan, YANG Zhongyan, LIU Peng, ZHAO Kun, MA Shengzhong, GAO Chunzheng. Effect of silencing TGF-β1 expression by small interfering RNA on ossification of the ligamentum flavum in mice [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(8): 27-33.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!